Edition:
United States

Sanofi SA (SASY.PA)

SASY.PA on Paris Stock Exchange

77.13EUR
7:27am EDT
Change (% chg)

€1.66 (+2.20%)
Prev Close
€75.47
Open
€75.66
Day's High
€77.36
Day's Low
€75.60
Volume
948,451
Avg. Vol
2,417,416
52-wk High
€80.44
52-wk Low
€67.39

Select another date:
Photo

French drugmaker Sanofi, Google to use data tech for innovations

PARIS French healthcare company Sanofi has teamed up with Google to work on innovations, aimed at using emerging data technologies to change how medicines and health services will be delivered in future.

French drugmaker Sanofi, Google to use data tech for innovations

PARIS, June 18 French healthcare company Sanofi has teamed up with Google to work on innovations, aimed at using emerging data technologies to change how medicines and health services will be delivered in future.

France's Sanofi bets on new CEO to drive sluggish drug sales

ZURICH In veteran drug salesman Paul Hudson, Sanofi's 100,000-plus employees are getting a new chief executive who relishes a good commercial fight.

NEWSMAKER-France's Sanofi bets on new CEO to drive sluggish drug sales

ZURICH, June 7 In veteran drug salesman Paul Hudson, Sanofi's 100,000-plus employees are getting a new chief executive who relishes a good commercial fight.

Drugmaker Sanofi hires Hudson from Novartis as CEO

PARIS Sanofi has poached Paul Hudson from Novartis to replace Chief Executive Olivier Brandicourt who will retire in September, France's biggest drugmaker said on Friday, helping send its shares almost 5 percent higher.

UPDATE 3-Drugmaker Sanofi hires Hudson from Novartis as CEO

* Hudson from Novartis to join Sanofi from Sept. 1 * Current CEO Brandicourt to retire * Shares up almost 5 percent (Adds share price, comment) By Matthias Blamont PARIS, June 7 Sanofi has poached Paul Hudson from Novartis to replace Chief Executive Olivier Brandicourt who will retire in September, France's biggest drugmaker said on Friday, helping send its shares almost 5 percent higher. Hudson, who is British, will take over on Sept. 1,

CORRECTED-UPDATE 2-Drugmaker Sanofi appoints Novartis' Hudson as CEO

PARIS, June 7 Sanofi has appointed Novartis executive Paul Hudson to replace CEO Olivier Brandicourt who will retire in September, France's biggest drugmaker said on Friday.

CORRECTED-Sanofi appoints Paul Hudson as CEO to replace retiring Brandicourt

PARIS, June 7 French pharma giant Sanofi appointed Paul Hudson as chief executive to replace Olivier Brandicourt, who will retire in September, the company said on Friday.

Exclusive: Sanofi poised to appoint Novartis' Hudson as CEO

PARIS Sanofi is poised to appoint Paul Hudson, a top executive with Switzerland's Novartis, to become the French drugmaker's next CEO from Sept. 1, a source familiar with the decision told Reuters on Thursday.

Select another date: